HPV Vaccine: An Effective but Underutilized Prevention Tool

Area of Science:

• Oncology
• Vaccinology
• Public Health

Background:

• Human Papillomavirus (HPV) vaccines are highly effective, safe, and cost-effective.
• Vaccine composition has evolved, broadening protection against HPV-related cancers.
• HPV vaccination demonstrates efficacy beyond primary prevention, reducing cervical lesion recurrence.

Purpose of the Study:

• To investigate differences in high-grade squamous intraepithelial lesions (H-SILs) and cervical carcinoma rates between vaccinated and unvaccinated women.
• To assess the impact of HPV vaccination on cervical cancer and pre-cancerous lesion incidence.

Main Methods:

• Retrospective study analyzing 2722 cases of cervical cancer or H-SIL diagnosed between 2003 and 2020 in Catania, Italy.
• Comparison of vaccination status (vaccinated vs. unvaccinated) in incident cases of H-SIL and cervical carcinoma.
• Analysis of vaccination timing relative to diagnosis.

Main Results:

• A statistically significant difference was observed between vaccinated and unvaccinated women regarding H-SILs and cervical cancer.
• 88% of all patients studied were unvaccinated; 85% of H-SIL patients were unvaccinated.
• Among vaccinated H-SIL patients, 96.5% initiated vaccination after diagnosis, indicating low uptake prior to lesion detection.

Conclusions:

• The HPV vaccine is an underutilized tool with the potential to eradicate cervical cancer.
• Increased vaccination rates are crucial for reducing HPV-related cancers.
• Enhanced communication strategies are needed to boost HPV vaccine uptake.